These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 713958)

  • 21. Harnessing autoimmunity (vitiligo) to treat melanoma: a myth or reality?
    Ram M; Shoenfeld Y
    Ann N Y Acad Sci; 2007 Sep; 1110():410-25. PubMed ID: 17911456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [APS I--a severe autoimmune disease with endocrine and non-endocrine symptoms].
    Gustafsson J; Alimohammadi M; Ekwall O; Gebre-Medhin G; Halldin-Stenlid M; Hedstrand H; Landgren E; Nilsson T; Rorsman F; Sköldberg F; Winqvist O; Kämpe O
    Lakartidningen; 2004 Jun; 101(24):2096-8, 2101-3. PubMed ID: 15282984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abnormal expression of MHC class II and ICAM-1 by melanocytes in vitiligo.
    al Badri AM; Foulis AK; Todd PM; Gariouch JJ; Gudgeon JE; Stewart DG; Gracie JA; Goudie RB
    J Pathol; 1993 Feb; 169(2):203-6. PubMed ID: 8095298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immunological changes in common vitiligo].
    Vignale R; Paciel J; Calandria L
    Med Cutan Ibero Lat Am; 1988; 16(4):343-7. PubMed ID: 3068448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-pigment-cell factors and mucocutaneous candidiasis.
    Nordlund JJ; Howanitz N; Bystryn JC; Forget BM; Lerner AB
    Arch Dermatol; 1981 Apr; 117(4):210-2. PubMed ID: 7212742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Humoral and cellular autoimmunity in genuine vitiligo studied by means of an antigen produced from melanoma cells].
    Höfs T
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(2):244-50. PubMed ID: 6179826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Graft exchange in vitiligo. Studies on the outcome of exchanging biopsies from vitiliginous skin to normal, pigmented skin and vice versa.
    Beck HI; Schmidt H
    Acta Derm Venereol; 1986; 66(4):311-5. PubMed ID: 2430401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitiligo: pathomechanisms and genetic polymorphism of susceptible genes.
    Shajil EM; Chatterjee S; Agrawal D; Bagchi T; Begum R
    Indian J Exp Biol; 2006 Jul; 44(7):526-39. PubMed ID: 16872041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unraveling the complex relationship between cancer immunity and autoimmunity: lessons from melanoma and vitiligo.
    Uchi H; Stan R; Turk MJ; Engelhorn ME; Rizzuto GA; Goldberg SM; Wolchok JD; Houghton AN
    Adv Immunol; 2006; 90():215-41. PubMed ID: 16730265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physiopathology and genetics of vitiligo.
    Passeron T; Ortonne JP
    J Autoimmun; 2005; 25 Suppl():63-8. PubMed ID: 16298511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequential immunohistochemical study of depigmenting and repigmenting minigrafts in vitiligo.
    Abdallah M; Abdel-Naser MB; Moussa MH; Assaf C; Orfanos CE
    Eur J Dermatol; 2003; 13(6):548-52. PubMed ID: 14721774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Vitiligo and other endocrine complications with an autoimmune basis].
    Herrera Pombo JL; Rodríguez ME; Rovira A; Martínez J; Salvador ML; Pérez Naranjo JM; de Castro A; Orbaneja JG
    Rev Clin Esp; 1982 Dec; 167(5):321-5. PubMed ID: 6897748
    [No Abstract]   [Full Text] [Related]  

  • 33. An immunohistological study of cutaneous lymphocytes in vitiligo.
    Badri AM; Todd PM; Garioch JJ; Gudgeon JE; Stewart DG; Goudie RB
    J Pathol; 1993 Jun; 170(2):149-55. PubMed ID: 8345407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immunopathologic study of vitiligo (author's transl)].
    Sawada Y; Ohashi M
    Nihon Hifuka Gakkai Zasshi; 1982 May; 92(6):621-8. PubMed ID: 6981009
    [No Abstract]   [Full Text] [Related]  

  • 35. Autoantibodies in vitiligo.
    Betterle C; Del Prete GF; Peserico A; Bersani G; Caracciolo F; Trisotto A; Poggi F
    Arch Dermatol; 1976 Sep; 112(9):1328. PubMed ID: 999321
    [No Abstract]   [Full Text] [Related]  

  • 36. [Vitiligo].
    Njoo MD; Westerhof W
    Ned Tijdschr Geneeskd; 1997 Apr; 141(16):759-64. PubMed ID: 9213796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum antibodies in vitiligo patients.
    Bystryn JC
    Clin Dermatol; 1989; 7(2):136-45. PubMed ID: 2667738
    [No Abstract]   [Full Text] [Related]  

  • 38. A biologist's reflections on dermatology.
    Billingham RE; Silvers WK
    J Invest Dermatol; 1971 Oct; 57(4):227-40. PubMed ID: 4256544
    [No Abstract]   [Full Text] [Related]  

  • 39. Contribution of modern immunological concepts to an understanding of diseases of the skin.
    Turk JL
    Br Med J; 1970 Aug; 3(5719):363-8. PubMed ID: 5451586
    [No Abstract]   [Full Text] [Related]  

  • 40. Autoantibodies as diagnostic and predictive markers of vitiligo.
    Kemp EH
    Autoimmunity; 2004 Jun; 37(4):287-90. PubMed ID: 15518043
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.